Back to GOLDMAN SACHS GROUP INC

TSHA
6 quarters

Position history for GOLDMAN SACHS GROUP INC's holdings in TAYSHA GENE THERAPIES INC

GOLDMAN SACHS GROUP INC holds 22.4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $100M as of 2026-Q1. The position was increased (+63.4% shares). TSHA represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$100M

Current Shares

22.4M

Total Value Change

+$98.3M

Total Shares Change

+21.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
22.4M
+63.4%
$100M0.0%$4.53
44
2025-Q4
Increased
13.7M
+2.3%
$75.3M0.0%$5.66
30
2025-Q3
Increased
13.4M
+6.3%
$43.8M0.0%$3.16
31
2025-Q2
Increased
12.6M
+3406.3%
$29.1M0.0%$2.38
46
2025-Q1
Decreased
359,007
-62.9%
$499,0190.0%$1.93
0
2024-Q4
New
967,144
-
$1.7M0.0%$1.73
36

Other major holders of TSHA: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, BlackRock, Inc., MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used